MURR

Oct. 24, 2024

University of Missouri initiative to boost radioisotope production

Expansion plans will scale up production at the University of Missouri Research Reactor, the only U.S. supplier of the lutetium-177 radioisotope.

Oct. 17, 2024

The need for NextGen MURR

The University of Missouri Research Reactor is leading the fight against cancer through unique radioisotopes. Watch an overview of the facility and the plans ahead for NextGen MURR.

Sep. 19, 2024

Saving lives one isotope at a time

Radioactive atoms produced at MU Research Reactor are key to advanced medical therapies.

Sep. 5, 2024

University of Missouri Research Reactor (MURR) wins Hawthorn Foundation Project of the Year Award

Recognition underscores MURR’s pivotal role in positioning Missouri as a leader in nuclear science and technology.

Aug. 20, 2024

MU Research Reactor partners with Institute of Nuclear Power Operations

This new collaboration will further enhance MURR’s operational standards, ensuring the highest levels of safety and efficiency.

July 24, 2024

Pioneering progress in cancer treatments

From its research reactor to revolutionary therapies, Mizzou’s innovations are shaping the future of precision medicine.

July 17, 2024

University of Missouri Research Reactor joins Nuclear Medicine Europe

July 12, 2024

Innovations and information

IT leaders from across the SEC gathered at Mizzou for their annual meeting.

June 4, 2024

Michael Hoehn II named inaugural program director of NextGen MURR

Hoehn will lead Mizzou’s transformational initiative to build a new state-of-the-art research reactor that will expand medical isotope production.

March 28, 2024

Innovative yttrium-90 radioisotopes revolutionize liver cancer treatment

Yttrium-90 radioisotopes produced at the University of Missouri Research Reactor are extending and improving the lives of patients with liver cancer.